Meriggioli, Matthew N.

Novartis Gene Therapies, Inc. (United States)

1 paper on CoChatORCID 0000-0001-7268-768X

Most cited papers

Verified
Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy
Mendell, J. R., Al-Zaidy, S. A., Lehman, K. J., McColly, M., Lowes, L. P., Alfano, L. N., Reash, N. F., Iammarino, M. A., Church, K. R., Kleyn, A., et al. (2021) · JAMA Neurology
Neurogenetic and Muscular Disorders ResearchVirus-based gene therapy research
Cited by 295

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free